FDA Provides Some Clarity to Complex Regulatory Environment for Molecular Diagnostics

Monday, November 10, 2014

Source: RAPS

A new guidance document issued by the US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) aims to clarify the regulatory processes by which certain molecular diagnostic devices are approved or cleared by federal regulators.

View All News »